Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
Clinical trial NCT03247088 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03247088
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-30
- Primary completion
- 2027-12-31
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.